These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12630232)

  • 1. [A new therapeutic alternative in chronic B-lymphocytic leukemia].
    Portal E
    Rev Infirm; 2002 Dec; (86):38-40. PubMed ID: 12630232
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberculosis due to Mycobacterium bovis after alemtuzumab administration.
    Abad S; Gyan E; Moachon L; Bouscary D; Sicard D; Dreyfus F; Blanche P
    Clin Infect Dis; 2003 Jul; 37(2):e27-8. PubMed ID: 12856232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation.
    Karlsson C; Norin S; Kimby E; Sander B; Porwit Macdonald A; Nilsson B; Johansson E; Mellstedt H; Lundin J; Osterborg A
    Leukemia; 2006 Dec; 20(12):2204-7. PubMed ID: 17051245
    [No Abstract]   [Full Text] [Related]  

  • 4. Campath-1H induced pure red cell aplasia in a patient with chronic lymphatic leukaemia.
    Thachil J; Salim R
    Leuk Res; 2007 Jul; 31(7):1025-6. PubMed ID: 17005249
    [No Abstract]   [Full Text] [Related]  

  • 5. NCCN: New directions in chronic lymphocytic leukemia.
    O'Brien S
    Cancer Control; 2001; 8(6 Suppl 2):114-7. PubMed ID: 11760553
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic lymphocytic leukaemia. Current strategy and new perspectives of treatment.
    Rai KR
    Haematologica; 1999 Jun; 84 Suppl EHA-4():94-5. PubMed ID: 10907481
    [No Abstract]   [Full Text] [Related]  

  • 7. Alemtuzumab.
    Am J Health Syst Pharm; 2001 Dec; 58(24):2372-3. PubMed ID: 11794950
    [No Abstract]   [Full Text] [Related]  

  • 8. Alemtuzumab for treatment of lymphoproliferative disorders.
    Haematologica; 2004 Dec; 89(12):1419. PubMed ID: 15590389
    [No Abstract]   [Full Text] [Related]  

  • 9. What choices are available for treatment of the patient with chronic lymphocytic leukemia who is fludarabine-refractory?
    Byrd JC; Rai KR
    Semin Oncol; 2000 Aug; 27(4):xii-xv; discussion xv-xvi. PubMed ID: 10950363
    [No Abstract]   [Full Text] [Related]  

  • 10. Campath-1H for chronic lymphocytic leukemia.
    Rai KR
    Clin Lymphoma; 2002 Sep; 3(2):73-4. PubMed ID: 12435278
    [No Abstract]   [Full Text] [Related]  

  • 11. Berlex Laboratories to market new treatment for B-CLL.
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):3. PubMed ID: 12113127
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab.
    Laurenti L; Tarnani M; Innocenti I; Savino G; Battendieri R; Larocca LM; Chiusolo P; Sorà F; Sica S; Efremov D; Leone G
    J Clin Oncol; 2008 Nov; 26(32):5299-301. PubMed ID: 18854557
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in the use of alemtuzumab in CLL.
    Stilgenbauer S
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):23-4. PubMed ID: 18322437
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of alemtuzumab in cutaneous chronic lymphocytic leukaemia involving facial skin.
    Grey M
    Br J Haematol; 2008 Jul; 142(1):1. PubMed ID: 18477054
    [No Abstract]   [Full Text] [Related]  

  • 15. Nursing care of patients receiving Campath.
    Seeley K; DeMeyer E
    Clin J Oncol Nurs; 2002; 6(3):138-43. PubMed ID: 11998606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alemtuzumab in chronic lymphocytic leukemia.
    James DF; Kipps TJ
    Future Oncol; 2007 Feb; 3(1):29-42. PubMed ID: 17280499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alemtuzumab.
    Williamson TS
    Clin J Oncol Nurs; 2001; 5(6):287-8. PubMed ID: 11899633
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current concepts in chronic lymphocytic leukemia. Better chances for young patients].
    Hallek M; Bergmann M; Goede V; Fingerle-Rowson G; Schweighofer C; Schmitt B; Wendtner CM; Emmerich B
    MMW Fortschr Med; 2003 Jul; 145(27-28):46-9. PubMed ID: 14587189
    [No Abstract]   [Full Text] [Related]  

  • 19. Campath-1H-induced complete remission of chronic lymphocytic leukemia despite p53 gene mutation and resistance to chemotherapy.
    Stilgenbauer S; Döhner H
    N Engl J Med; 2002 Aug; 347(6):452-3. PubMed ID: 12167696
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous cryptococcosis with alemtuzumab in a patient treated for chronic lymphocytic leukaemia.
    Dilhuydy MS; Jouary T; Demeaux H; Ravaud A
    Br J Haematol; 2007 Jun; 137(6):490. PubMed ID: 17425643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.